Molecular Imaging Outlook

Sponsored by an educational grant from Siemens Medical Solutions

September 2006

Molecular imaging brings the vision of personalized medicine into focus

MI identifies variations in disease expression and therapeutic responsiveness for better clinical decision-making


Read More »
Scientific discovery adds spice to Britton Chance's long life

Dr. Britton Chance is one of the most inventive people in biomedical imaging.


Read More »
SUVs earn cheers for research but jeers for routine clinical use

In the quantitative world of molecular imaging, the standardized uptake value (SUV) looms large as a key measure of tumor aggressiveness and therapeutic response.


Read More »
MDs prove slow to adopt FDG-PET for cervical cancer staging

MI techniques recommend against unnecessary surgeries and monitor therapy


Read More »
Informatics sifts complex MI data

Computer tools guide research and streamline interpretation of clinical imaging results


Read More »
SPIO agents undergo scrutiny for cell tracking

Researchers weigh alternatives while they search for optimal ferric material


Read More »
Nuclear medicine embraces MI applications

Two top meetings showcase MI progress, while investment in basic sciences soars


Read More »
Combined approach evaluates breast cancer treatment progress

CONTEXT: Combining proton MR spectroscopic imaging, sodium MR, and PET/CT imaging may be an effective multimodality approach for detecting early response to chemotherapy in breast cancer patients, according to Dr. Michael Jacobs, a radiologist at Johns Hopkins School of Medicine.


Read More »
MRI tracks transplanted pancreatic cells labeled with iron-oxide contrast

The emerging therapy of islet transplantation has shown great promise for diabetes patients.


Read More »
Human trial of anti-F-18 FACBC tracer shows promise for prostate cancer

CONTEXT: While prostate-specific antigen testing and biopsy are the most conclusive ways for detecting prostate cancer, no clear-cut imaging technique exists for initial diagnosis and staging.


Read More »
Automated analysis of FDG-PET scans may predict rate of cognitive decline

FDG-PET imaging has become an accepted, reimburseable approach for diagnosing Alzheimer's and other neurodegenerative diseases.


Read More »